HomeCompareSLGC vs STAG

SLGC vs STAG: Dividend Comparison 2026

SLGC yields 95.24% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SLGC wins by $3.18M in total portfolio value
10 years
SLGC
SLGC
● Live price
95.24%
Share price
$2.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.20M
Annual income
$1,043,960.64
Full SLGC calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — SLGC vs STAG

📍 SLGC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSLGCSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SLGC + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SLGC pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLGC
Annual income on $10K today (after 15% tax)
$8,095.24/yr
After 10yr DRIP, annual income (after tax)
$887,366.54/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, SLGC beats the other by $886,973.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLGC + STAG for your $10,000?

SLGC: 50%STAG: 50%
100% STAG50/50100% SLGC
Portfolio after 10yr
$1.61M
Annual income
$522,211.43/yr
Blended yield
32.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

SLGC
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Price Target
$12.00
+471.4% upside vs current
Range: $9.00 — $15.00
Altman Z
2.1
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLGC buys
0
STAG buys
0
No recent congressional trades found for SLGC or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSLGCSTAG
Forward yield95.24%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$3.20M$18.3K
Annual income after 10y$1,043,960.64$462.22
Total dividends collected$2.84M$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$12.00$45.00

Year-by-year: SLGC vs STAG ($10,000, DRIP)

YearSLGC PortfolioSLGC Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$20,224$9,523.81$10,665$345.09+$9.6KSLGC
2$39,640$18,000.72$11,364$357.70+$28.3KSLGC
3$75,390$32,974.56$12,098$370.43+$63.3KSLGC
4$139,277$58,609.85$12,869$383.28+$126.4KSLGC
5$250,220$101,193.83$13,677$396.23+$236.5KSLGC
6$437,643$169,907.92$14,524$409.27+$423.1KSLGC
7$746,012$277,733.46$15,411$422.41+$730.6KSLGC
8$1,240,688$442,455.79$16,339$435.61+$1.22MSLGC
9$2,015,243$687,706.55$17,311$448.89+$2.00MSLGC
10$3,200,271$1,043,960.64$18,327$462.22+$3.18MSLGC

SLGC vs STAG: Complete Analysis 2026

SLGCStock

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.

Full SLGC Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this SLGC vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLGC vs SCHDSLGC vs JEPISLGC vs OSLGC vs KOSLGC vs MAINSLGC vs PLDSLGC vs EQRSLGC vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.